AI Insight
Researchers tested an experimental antiviral pill in ferrets infected with a measles-like virus and found it prevented transmission through airborne and close-contact routes. The treatment was effective when administered shortly before or after exposure to the virus, and it reduced both the duration of illness and the contagious period in infected animals. The drug shows potential as a complementary tool to vaccination for controlling measles outbreaks.
Why it matters
This antiviral could provide a new option for containing measles outbreaks, particularly in situations where vaccination alone is insufficient or when rapid intervention is needed after exposure. The ability to prevent transmission and shorten contagious periods could significantly reduce the spread of measles in communities experiencing outbreaks.
Understand the Science
An experimental pill prevented a measles-like virus from spreading through the air or through close contact in ferrets. It worked when given shortly before or after exposure and also shortened illness and the period when infected animals remained contagious. Researchers say the drug could one day complement vaccination and make outbreaks easier to contain.
Source: A new antiviral could stop measles before an outbreak takes off